These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32325700)

  • 21. Recent update on IGF-1/IGF-1R signaling axis as a promising therapeutic target for triple-negative breast cancer.
    Kumar S; Chaudhri S
    Pathol Res Pract; 2024 Nov; 263():155620. PubMed ID: 39357179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
    Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
    Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
    Li Z; Su P; Ding Y; Gao H; Yang H; Li X; Yang X; Xia Y; Zhang C; Fu M; Wang D; Zhang Y; Zhuo S; Zhu J; Zhuang T
    Cell Commun Signal; 2022 Oct; 20(1):164. PubMed ID: 36280829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis.
    Jiang K; Liu P; Xu H; Liang D; Fang K; Du S; Cheng W; Ye L; Liu T; Zhang X; Gong P; Shao S; Wang Y; Meng S
    Oncogene; 2020 Jul; 39(27):5015-5030. PubMed ID: 32523092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.
    Deng Q; Jiang G; Wu Y; Li J; Liang W; Chen L; Su Q; Li W; Du J; Wong CKC; Chen Z; Wang H
    J Hazard Mater; 2018 Aug; 355():1-9. PubMed ID: 29758456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
    Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
    Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals.
    An P; Li J; Lu L; Wu Y; Ling Y; Du J; Chen Z; Wang H
    Eur J Pharmacol; 2019 Feb; 845():16-23. PubMed ID: 30582912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling.
    Shen M; Jiang YZ; Wei Y; Ell B; Sheng X; Esposito M; Kang J; Hang X; Zheng H; Rowicki M; Zhang L; Shih WJ; Celià-Terrassa T; Liu Y; Cristea I; Shao ZM; Kang Y
    Cancer Cell; 2019 Jan; 35(1):64-80.e7. PubMed ID: 30612941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
    Luey BC; May FE
    Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation.
    Sato F; Sagara A; Tajima K; Miura S; Inaba K; Ando Y; Oku T; Murakami T; Kato Y; Yumoto T
    Breast Cancer Res Treat; 2022 Jul; 194(2):243-256. PubMed ID: 35624176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia-induced YAP activation and focal adhesion turnover to promote cell migration in mesenchymal TNBC cells.
    Nguyen TMH; Lai YS; Chen YC; Lin TC; Nguyen NT; Chiu WT
    Cancer Med; 2023 Apr; 12(8):9723-9737. PubMed ID: 36757143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis.
    De Vincenzo A; Belli S; Franco P; Telesca M; Iaccarino I; Botti G; Carriero MV; Ranson M; Stoppelli MP
    Int J Cancer; 2019 Nov; 145(10):2827-2839. PubMed ID: 31381136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation.
    Cho YL; Hur SM; Kim JY; Kim JH; Lee DK; Choe J; Won MH; Ha KS; Jeoung D; Han S; Ryoo S; Lee H; Min JK; Kwon YG; Kim DH; Kim YM
    J Biol Chem; 2015 Jan; 290(1):467-77. PubMed ID: 25391655
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Solomon VR; Alizadeh E; Bernhard W; Hartimath SV; Hill W; Chekol R; Barreto KM; Geyer CR; Fonge H
    Mol Pharm; 2019 Dec; 16(12):4807-4816. PubMed ID: 31518138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors.
    Castaño Z; Marsh T; Tadipatri R; Kuznetsov HS; Al-Shahrour F; Paktinat M; Greene-Colozzi A; Nilsson B; Richardson AL; McAllister SS
    Cancer Discov; 2013 Aug; 3(8):922-35. PubMed ID: 23689072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGF-1R/YAP signaling pathway is involved in collagen V-induced insulin biosynthesis and secretion in rat islet INS-1 cells.
    Zhu Y; Chen S; Liu W; Xu F; Lu J; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Connect Tissue Res; 2022 Sep; 63(5):498-513. PubMed ID: 35129018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled Signaling-Insulin-Like Growth Factor Receptor Endocytosis and Presence at Intracellular Compartments.
    Rieger L; O'Connor R
    Front Endocrinol (Lausanne); 2020; 11():620013. PubMed ID: 33584548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FAK tyrosine 407 organized with integrin αVβ5 in Hs578Ts(i)8 advanced triple-negative breast cancer cells.
    Payan I; McDonnell S; Torres HM; Steelant WF; Van Slambrouck S
    Int J Oncol; 2016 May; 48(5):2043-54. PubMed ID: 26984508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.